Listen and follow our podcasts on:

This educational programme is supported by an Independent Educational Grant from Ipsen

In these two podcasts, medical experts and a patient representative share their perspectives on new Primary Biliary Cholangitis (PBC) data from EASL 2023.

In podcast 1, physicians Dr Emma Culver and Prof. Gideon Hirschfield discuss the evidence of cancer risk associated with PBC, how liver stiffness progression is associated with prognosis; and outcomes and response prediction in second-line therapy.

In podcast 2, CEO of the PBC Foundation, Robert Mitchell-Thain, and autoimmune specialist nurse Kath Houghton explore the impact of PBC symptoms and new instruments for assessing them. They also discuss data highlighting the importance of the current move toward normalisation of liver biomarkers and take a look at some early data on future therapies and therapeutic targets.

Transcripts, with details of the presentations covered, are available for download.

 

Consultant Hepatologist and Honorary Senior Lecturer at the John Radcliffe Hospital and University of Oxford. Clinical Lead for autoimmune and cholestatic liver disease in Oxford. National Committee Chair for UK-IgG4, Steering Committee for British Association for the Study of the Liver Immune-Mediated Liver Disease Special Interest Group and UK-PSC, and Scientific Committee for UK-AIH. Medical Advisory Board for the PBC Foundation and Scientific Advisory Board for PSC Support. Translational funding from the Welcome Trust, NIHR Academy of Medical Sciences, NIHR BRC Oxford, and Oxford Charitable Fund.

Dr Emma Culver has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Advisory Boards for Horizon Therapeutics, Zenus Biopharma, Sanofi, Moderna and Falk Pharma

Presenter fees for Falk Pharma, Horizon and Intercept.

Prof. Gideon Hirschfield has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Prof. Hirschfield received financial support/sponsorship from Advanz, Cymabay, Escient, GSK, Intercept, Ipsen, Miram and Pliant

Kath qualified as a nurse at Ormskirk Hospital, West Lancashire.  She gained experience in major abdominal and vascular theatres at both Ninewells Hospital in Dundee and at Heartlands Hospital in Birmingham.  In 2000 she joined the team at the Royal Victoria Infirmary in Newcastle upon Tyne as an endoscopy nurse before taking up a dual Nurse Specialist/research role with the Upper GI Regional Team at the Northern Oesophageal Gastric Cancer Unit. 

 

Since 2013 Kath has worked in the Hepatology Unit at the Freeman hospital, within the Newcastle Hospitals NHS Foundation Trust, where she has developed an interested in PBC. Currently she works in a dual role covering both research and as the first dedicated Autoimmune Liver Nurse Specialist within the trust, where she focused on patients with PBC.  Kath set up a nurse led PBC telephone clinic and helped to manage the PBC ODN.  She is also part of the PBC Connect educational cohort along with 2 consultants and 2 other nurse specialists from Cambridge, London, Birmingham and Oxford, helping to educate around PBC.

 

CEO at PBC Foundation, Chair of Global Liver Institute’s Paediatric and Rare Liver Disease Council and is also Chair of umbrella organisation, Liver Patients International. PBC Foundation is a UK-based international patient support and advocacy non-profit organisation that supports over 20,000 patients in over 80 countries around the world

Mr Robert Mitchell-Thain has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

The PBC Foundation has received funding from Advanz, Calliditas, Cara, Cymabay, Escient, GSK, Intercept, Ipsen, Mirum, and Umecrine.

Listen and follow our podcasts on:

This educational programme is supported by an Independent Educational Grant from This educational programme is supported by an Independent Educational Grant from Ipsen

In these two podcasts, medical experts and a patient representative share their perspectives on new Primary Biliary Cholangitis (PBC) data from EASL 2023.

In podcast 1, physicians Dr Emma Culver and Prof. Gideon Hirschfield discuss the evidence of cancer risk associated with PBC, how liver stiffness progression is associated with prognosis; and outcomes and response prediction in second-line therapy.

In podcast 2, CEO of the PBC Foundation, Robert Mitchell-Thain, and autoimmune specialist nurse Kath Houghton explore the impact of PBC symptoms and new instruments for assessing them. They also discuss data highlighting the importance of the current move toward normalisation of liver biomarkers and take a look at some early data on future therapies and therapeutic targets.

Transcripts, with details of the presentations covered, are available for download.

 

Consultant Hepatologist and Honorary Senior Lecturer at the John Radcliffe Hospital and University of Oxford. Clinical Lead for autoimmune and cholestatic liver disease in Oxford. National Committee Chair for UK-IgG4, Steering Committee for British Association for the Study of the Liver Immune-Mediated Liver Disease Special Interest Group and UK-PSC, and Scientific Committee for UK-AIH. Medical Advisory Board for the PBC Foundation and Scientific Advisory Board for PSC Support. Translational funding from the Welcome Trust, NIHR Academy of Medical Sciences, NIHR BRC Oxford, and Oxford Charitable Fund.

Dr Emma Culver has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Advisory Boards for Horizon Therapeutics, Zenus Biopharma, Sanofi, Moderna and Falk Pharma

Presenter fees for Falk Pharma, Horizon and Intercept.

Prof. Gideon Hirschfield has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Prof. Hirschfield received financial support/sponsorship from Advanz, Cymabay, Escient, GSK, Intercept, Ipsen, Miram and Pliant

Kath qualified as a nurse at Ormskirk Hospital, West Lancashire.  She gained experience in major abdominal and vascular theatres at both Ninewells Hospital in Dundee and at Heartlands Hospital in Birmingham.  In 2000 she joined the team at the Royal Victoria Infirmary in Newcastle upon Tyne as an endoscopy nurse before taking up a dual Nurse Specialist/research role with the Upper GI Regional Team at the Northern Oesophageal Gastric Cancer Unit. 

 

Since 2013 Kath has worked in the Hepatology Unit at the Freeman hospital, within the Newcastle Hospitals NHS Foundation Trust, where she has developed an interested in PBC. Currently she works in a dual role covering both research and as the first dedicated Autoimmune Liver Nurse Specialist within the trust, where she focused on patients with PBC.  Kath set up a nurse led PBC telephone clinic and helped to manage the PBC ODN.  She is also part of the PBC Connect educational cohort along with 2 consultants and 2 other nurse specialists from Cambridge, London, Birmingham and Oxford, helping to educate around PBC.

 

CEO at PBC Foundation, Chair of Global Liver Institute’s Paediatric and Rare Liver Disease Council and is also Chair of umbrella organisation, Liver Patients International. PBC Foundation is a UK-based international patient support and advocacy non-profit organisation that supports over 20,000 patients in over 80 countries around the world

Mr Robert Mitchell-Thain has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

The PBC Foundation has received funding from Advanz, Calliditas, Cara, Cymabay, Escient, GSK, Intercept, Ipsen, Mirum, and Umecrine.

Programme summary
Listen to the podcast now
Other episodes of this series
Primary Biliary Cholangitis Highlights from EASL 2023

Primary Biliary Cholangitis Highlights from EASL 2023

Episode 1: PBC Highlights from EASL

Current Episode
Primary Biliary Cholangitis Highlights from EASL 2023

Primary Biliary Cholangitis Highlights from EASL 2023

Episode 2: PBC Highlights from EASL 2023

Share this programme
This educational programme is supported by an Independent Educational Grant from Ipsen
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen
Endorsement
I agree that this educational programme:

Was valuable to me

1/4
Programme summary
  • clock Duration MIN
  • clock Language(s) flag
Listen to the podcast now
Other episodes of this series
Primary Biliary Cholangitis Highlights from EASL 2023

Primary Biliary Cholangitis Highlights from EASL 2023

Episode 1: PBC Highlights from EASL

Current Episode
Primary Biliary Cholangitis Highlights from EASL 2023

Primary Biliary Cholangitis Highlights from EASL 2023

Episode 2: PBC Highlights from EASL 2023

Share this programme
This educational programme is supported by an Independent Educational Grant from Ipsen
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen
Endorsement
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

conference-update Conference update

Episode

2

of 2

episode
Oncology Rare diseases Endocrinology 
Actualités du Congrès l’ENETS 2026

Points de vue d’experts sur les dernières données concernant le cancer neuroendocrinien

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

Cette vidéo est soutenue par une subvention indépendante à visée éducative d’Ipsen.  Les contenus publiés sur ce site internet sont sous la responsabilité de leurs auteurs. Certaines données scientifiques publiées sur ce site sont susceptibles de ne pas être validées par la commission d’Autorisation de Mise sur le Marché, et ne doivent pas être mises en pratique. Elles doivent être lues et comprises avec le plus grand discernement et sont données dans leur cadre de la diffusion de l’information sur l’état actuel de la recherche auprès de la communauté scientifique internationale  
conference-update Conference update

Episode

1

of 2

episode
Oncology Rare diseases Endocrinology 
Update from ENETS 2026

Experts share their views on latest data in neuroendocrine cancer

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.
patient-support Patient Support
Rare diseases 
Understanding narcolepsy

Persistent sleepiness: when to look closer

Experts
Prof. Yves Dauvilliers
Endorsed by
EU-NN ANC
eNAP
  • clock 2 MIN
  • calendar Jan 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Takeda
patient-support Patient Support

Episode

2

of 2

episode
Oncology Endocrinology Rare diseases 
Thriving beyond an EP-NEC diagnosis

Perspectives on treatment and care 

Experts
Jessica Thomas
Endorsed by
NET-Research-Foundation Minkhas mission
  • clock 4 MIN
  • calendar Dec 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim 
patient-support Patient Support

Episode

1

of 2

episode
Oncology Endocrinology Rare diseases 
Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC)

Insights for patients and care partners 

Experts
Meredith Cummins
Endorsed by
INCA
NeuroEndocrine Cancer Australia Neuroendocrine Cancer Foundation NET-Research-Foundation
Neuroendocrine Cancer UK Minkhas mission
  • clock 5 MIN
  • calendar Dec 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim 
podcast Video podcast
Oncology Endocrinology Rare diseases 
Understanding EP-NEC: Through diagnosis, treatment, and support

A medical oncologist and a patient advocate share their perspectives

Experts
Dr Aman Chauhan, Susan Meckler-Plummer, RN
Endorsed by
Minkhas mission Neuroendocrine Cancer UK Neuroendocrine Cancer Foundation
NET-Research-Foundation
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Nov 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim